CLYM
CLYM
US28658R1068
Climb Bio, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue -- --
--
Cost of Revenue -- --
--
Gross Profit -- --
--
67.883.000 30.361.000
123.6%
Operating Income -67.883.000 -30.361.000
123.6%
Pretax Income -59.851.000 -73.897.000
19.0%
Net Income Common Stockholders -59.851.000 -73.897.000
19.0%
-- --
--
-- --
--
ende